What is Translational Software?
Founded in 2009 and headquartered in Bellevue, Washington, Translational Software specializes in transforming complex genetic data into actionable, evidence-based recommendations. Their platform-agnostic solutions are designed to simplify genomic decision support, making advanced genetic insights accessible and practical for various applications. The company's focus on bridging the gap between raw genetic information and clinical utility positions it as a key player in the rapidly evolving field of precision medicine.
How much funding has Translational Software raised?
Translational Software has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Translational Software?
With the recent influx of capital and strategic investment, Translational Software is poised for significant expansion. The large-scale, late-stage funding context suggests a focus on scaling operations, enhancing product development, and potentially broadening market reach. This strategic financing will likely enable the company to further refine its genomic decision support platform, integrate with more healthcare systems, and solidify its position as a leader in translating genetic data into tangible health outcomes. The company's ability to simplify complex genetic information will be crucial as the demand for personalized medicine continues to grow.
See full Translational Software company page
